Literature DB >> 17692200

[Hepatitis E virus: zoonotic implications].

Nereida Jiménez de Oya1, Estela Escribano-Romero, Ana Belén Blázquez, Juan Carlos Saiz.   

Abstract

The Hepatitis E virus (HEV) is transmitted primarily by the feco-oral route throughout contaminated water and/or food, and is one of the main causes of acute hepatitis worldwide. Hepatitis E shows a high mobility but a low mortality rate, except in pregnant women, where it can be as high as 30%. HEV causes sporadic cases and epidemic outbreaks, mainly in Africa, Asia and Central America. In Europe, there is an increase in the number of reported autochthonous cases no related with travel to endemic areas. In addition, HEV also infects animals, including pigs, and its zoonotic potential has been recently demonstrated. In fact, porcine and human strains of the same area are genetically more closely related to each other than to strains of the same species but a different geographical region, and there are data suggesting that people in close contact with pigs presents a higher prevalence of specific anti-HEV antibodies. All together, these data have drove to an increase interest in determining the incidence of the disease in animals, its possible zoonotic risk, and its implications for human health. In the present article we revised the current knowledge about HEV, with special emphasis in the possible consequences of its zoonotic potential.

Entities:  

Mesh:

Year:  2007        PMID: 17692200     DOI: 10.1157/13108819

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  2 in total

1.  Fulminant hepatitis E in a woman taking oral contraceptive medication.

Authors:  Maria Luisa Mateos Lindemann; Javier Graus Morales; Salceda Fernández-Barredo; Mario Rodríguez Domínguez; Fernando García de la Hoz; Philippe Halfon; Maria Teresa Pérez Gracia
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 2.  Hepatitis E Virus and Related Viruses in Animals.

Authors:  D Thiry; A Mauroy; N Pavio; M A Purdy; N Rose; E Thiry; E F de Oliveira-Filho
Journal:  Transbound Emerg Dis       Date:  2015-04-27       Impact factor: 5.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.